- Report
- February 2024
- 86 Pages
Global
From €3500EUR$3,904USD£3,093GBP
- Report
- May 2022
- 92 Pages
Global
From €3500EUR$3,904USD£3,093GBP
- Report
- January 2021
- 139 Pages
China, Global
From €3000EUR$3,346USD£2,651GBP
- Report
- March 2024
- 50 Pages
Global
From €2545EUR$2,650USD£2,173GBP
- Report
- November 2021
- 620 Pages
Global
From €3842EUR$4,000USD£3,280GBP
- Report
- March 2020
- 194 Pages
Global
From €5158EUR$5,370USD£4,403GBP
- Report
- April 2023
- 147 Pages
Global
From €5762EUR$5,999USD£4,919GBP
Oseltamivir, also known as Tamiflu, is an antiviral medication used to treat and prevent influenza. It is a neuraminidase inhibitor, meaning it works by blocking the activity of the influenza virus in the body. Oseltamivir is used to treat both seasonal and pandemic influenza, and is the only antiviral drug approved by the US Food and Drug Administration for the treatment of influenza. It is also used to prevent influenza in people who have been exposed to the virus.
Oseltamivir is available in both oral and intravenous forms, and is typically prescribed for five days. Common side effects include nausea, vomiting, and diarrhea. It is important to note that oseltamivir is not effective against other types of infectious diseases.
The oseltamivir market is highly competitive, with several major pharmaceutical companies producing the drug. These include Roche, GlaxoSmithKline, Sanofi, and Mylan. Show Less Read more